US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist

1.050
-0.020-1.87%

Close Nov 29 13:00 ET

1.080
+0.030+2.86%

Post 17:01 ET

79.64MMarket Cap-2333P/E (TTM)

Clearside Biomedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-18.09%23.59M

-16.13%29.36M

-14.64%35.36M

-40.07%28.92M

-46.04%28.8M

20.57%35.01M

20.50%41.42M

58.56%48.26M

-Cash and cash equivalents

-51.78%13.89M

-47.90%18.24M

-14.64%35.36M

-40.07%28.92M

-46.04%28.8M

20.57%35.01M

20.50%41.42M

58.56%48.26M

-Short-term investments

--9.7M

--11.12M

----

Receivables

-10.66%788K

--0

--170K

617.07%882K

107.32%255K

----

--0

-Accounts receivable

-10.66%788K

--0

--170K

617.07%882K

107.32%255K

----

--0

Prepaid assets

-35.45%721K

-32.84%364K

-25.59%567K

2.56%722K

6.69%1.12M

23.46%542K

35.35%762K

-23.56%704K

Other current assets

-7.14%13K

-85.57%44K

-50.00%193K

-29.16%311K

-95.50%14K

-22.59%305K

13.86%386K

-43.65%439K

Total current assets

-18.50%25.11M

-17.56%29.77M

-15.16%36.12M

-39.02%30.12M

-43.83%30.82M

20.40%36.11M

20.68%42.57M

17.24%49.4M

Non current assets

Net PPE

12.39%4.02M

35.70%4.14M

90.51%4M

106.46%3.87M

439.22%3.58M

410.55%3.05M

235.68%2.1M

208.40%1.87M

-Gross PPE

13.63%5.09M

30.42%5.13M

66.72%4.95M

75.60%4.79M

157.04%4.48M

140.34%3.93M

82.41%2.97M

74.46%2.73M

-Accumulated depreciation

-18.56%-1.07M

-12.22%-992K

-9.22%-948K

-7.85%-920K

16.51%-900K

14.92%-884K

13.29%-868K

10.68%-853K

Other non current assets

0.00%30K

-81.25%30K

Total non current assets

12.29%4.05M

35.35%4.17M

89.24%4.03M

104.78%3.9M

338.03%3.61M

306.61%3.08M

171.08%2.13M

147.98%1.9M

Total assets

-15.28%29.16M

-13.40%33.93M

-10.19%40.14M

-33.69%34.02M

-38.19%34.42M

27.45%39.19M

23.95%44.7M

19.58%51.3M

Liabilities

Current liabilities

Payables

26.46%2.36M

-16.44%1.58M

-14.49%1.36M

110.00%2.21M

7.36%1.87M

-28.67%1.89M

14.18%1.59M

11.58%1.05M

-accounts payable

26.46%2.36M

-16.44%1.58M

-14.49%1.36M

110.00%2.21M

7.36%1.87M

-28.67%1.89M

14.18%1.59M

11.58%1.05M

Current accrued expenses

-39.70%1.39M

56.51%2.67M

59.32%3.48M

-1.49%2.31M

35.44%2.3M

17.76%1.7M

32.14%2.18M

60.63%2.34M

Current debt and capital lease obligation

3.04%373K

3.06%370K

3.09%367K

4.30%364K

-11.06%362K

-9.11%359K

-8.95%356K

-9.82%349K

-Current capital lease obligation

3.04%373K

3.06%370K

3.09%367K

4.30%364K

-11.06%362K

-9.11%359K

-8.95%356K

-9.82%349K

Current deferred liabilities

--0

-36.62%225K

-46.43%150K

-63.41%75K

--0

--355K

41.41%280K

--205K

Current liabilities

-4.15%5.59M

11.38%5.87M

19.38%5.95M

17.81%6.81M

12.13%5.84M

-2.21%5.27M

19.92%4.98M

24.63%5.78M

Non current liabilities

Long term debt and capital lease obligation

-43.09%412K

-38.07%493K

-34.03%572K

-30.66%649K

--724K

658.10%796K

333.50%867K

225.00%936K

-Long term capital lease obligation

-43.09%412K

-38.07%493K

-34.03%572K

-30.66%649K

--724K

658.10%796K

333.50%867K

225.00%936K

Derivative product liabilities

--8.76M

--9.12M

--11.04M

----

Other non current liabilities

20.83%49.19M

22.69%46.73M

22.82%44.39M

24.99%42.47M

27.48%40.71M

--38.09M

--36.14M

--33.98M

Total non current liabilities

40.84%58.36M

44.91%56.35M

51.31%56M

23.50%43.12M

29.74%41.43M

36,932.38%38.88M

18,405.50%37.01M

12,022.57%34.91M

Total liabilities

35.29%63.95M

40.90%62.22M

47.52%61.95M

22.69%49.93M

27.28%47.27M

703.16%44.16M

864.07%42M

725.81%40.7M

Shareholders'equity

Share capital

20.97%75K

19.35%74K

21.31%74K

3.28%63K

3.33%62K

1.67%61K

-common stock

20.97%75K

19.35%74K

21.31%74K

3.28%63K

3.33%62K

1.67%61K

-Preferred stock

--0

Retained earnings

-10.09%-347.97M

-10.90%-340.28M

-11.75%-332.69M

-11.26%-320.92M

-13.39%-316.09M

-13.24%-306.82M

-13.14%-297.72M

-12.90%-288.44M

Paid-in capital

3.27%313.1M

3.36%311.92M

3.48%310.8M

1.99%304.95M

1.99%303.18M

1.91%301.79M

1.89%300.36M

1.90%298.98M

Gains losses not affecting retained earnings

--5K

---1K

----

Total stockholders'equity

-170.75%-34.79M

-468.77%-28.29M

-907.78%-21.81M

-250.01%-15.91M

-169.28%-12.85M

-119.70%-4.97M

-91.48%2.7M

-72.07%10.61M

Total equity

-170.75%-34.79M

-468.77%-28.29M

-907.78%-21.81M

-250.01%-15.91M

-169.28%-12.85M

-119.70%-4.97M

-91.48%2.7M

-72.07%10.61M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-18.09%23.59M	-16.13%29.36M	-14.64%35.36M	-40.07%28.92M	-40.07%28.92M	-46.04%28.8M	20.57%35.01M	20.50%41.42M	58.56%48.26M	58.56%48.26M
-Cash and cash equivalents	-51.78%13.89M	-47.90%18.24M	-14.64%35.36M	-40.07%28.92M	-40.07%28.92M	-46.04%28.8M	20.57%35.01M	20.50%41.42M	58.56%48.26M	58.56%48.26M
-Short-term investments	--9.7M	--11.12M	----	----	----	----	----	----	----	----
Receivables	-10.66%788K	--0	--0	--170K	--170K	617.07%882K	107.32%255K	----	--0	--0
-Accounts receivable	-10.66%788K	--0	--0	--170K	--170K	617.07%882K	107.32%255K	----	--0	--0
Prepaid assets	-35.45%721K	-32.84%364K	-25.59%567K	2.56%722K	2.56%722K	6.69%1.12M	23.46%542K	35.35%762K	-23.56%704K	-23.56%704K
Other current assets	-7.14%13K	-85.57%44K	-50.00%193K	-29.16%311K	-29.16%311K	-95.50%14K	-22.59%305K	13.86%386K	-43.65%439K	-43.65%439K
Total current assets	-18.50%25.11M	-17.56%29.77M	-15.16%36.12M	-39.02%30.12M	-39.02%30.12M	-43.83%30.82M	20.40%36.11M	20.68%42.57M	17.24%49.4M	17.24%49.4M
Non current assets
Net PPE	12.39%4.02M	35.70%4.14M	90.51%4M	106.46%3.87M	106.46%3.87M	439.22%3.58M	410.55%3.05M	235.68%2.1M	208.40%1.87M	208.40%1.87M
-Gross PPE	13.63%5.09M	30.42%5.13M	66.72%4.95M	75.60%4.79M	75.60%4.79M	157.04%4.48M	140.34%3.93M	82.41%2.97M	74.46%2.73M	74.46%2.73M
-Accumulated depreciation	-18.56%-1.07M	-12.22%-992K	-9.22%-948K	-7.85%-920K	-7.85%-920K	16.51%-900K	14.92%-884K	13.29%-868K	10.68%-853K	10.68%-853K
Other non current assets	0.00%30K	0.00%30K	0.00%30K	0.00%30K	0.00%30K	-81.25%30K	-81.25%30K	-81.25%30K	-81.25%30K	-81.25%30K
Total non current assets	12.29%4.05M	35.35%4.17M	89.24%4.03M	104.78%3.9M	104.78%3.9M	338.03%3.61M	306.61%3.08M	171.08%2.13M	147.98%1.9M	147.98%1.9M
Total assets	-15.28%29.16M	-13.40%33.93M	-10.19%40.14M	-33.69%34.02M	-33.69%34.02M	-38.19%34.42M	27.45%39.19M	23.95%44.7M	19.58%51.3M	19.58%51.3M
Liabilities
Current liabilities
Payables	26.46%2.36M	-16.44%1.58M	-14.49%1.36M	110.00%2.21M	110.00%2.21M	7.36%1.87M	-28.67%1.89M	14.18%1.59M	11.58%1.05M	11.58%1.05M
-accounts payable	26.46%2.36M	-16.44%1.58M	-14.49%1.36M	110.00%2.21M	110.00%2.21M	7.36%1.87M	-28.67%1.89M	14.18%1.59M	11.58%1.05M	11.58%1.05M
Current accrued expenses	-39.70%1.39M	56.51%2.67M	59.32%3.48M	-1.49%2.31M	-1.49%2.31M	35.44%2.3M	17.76%1.7M	32.14%2.18M	60.63%2.34M	60.63%2.34M
Current debt and capital lease obligation	3.04%373K	3.06%370K	3.09%367K	4.30%364K	4.30%364K	-11.06%362K	-9.11%359K	-8.95%356K	-9.82%349K	-9.82%349K
-Current capital lease obligation	3.04%373K	3.06%370K	3.09%367K	4.30%364K	4.30%364K	-11.06%362K	-9.11%359K	-8.95%356K	-9.82%349K	-9.82%349K
Current deferred liabilities	--0	-36.62%225K	-46.43%150K	-63.41%75K	-63.41%75K	--0	--355K	41.41%280K	--205K	--205K
Current liabilities	-4.15%5.59M	11.38%5.87M	19.38%5.95M	17.81%6.81M	17.81%6.81M	12.13%5.84M	-2.21%5.27M	19.92%4.98M	24.63%5.78M	24.63%5.78M
Non current liabilities
Long term debt and capital lease obligation	-43.09%412K	-38.07%493K	-34.03%572K	-30.66%649K	-30.66%649K	--724K	658.10%796K	333.50%867K	225.00%936K	225.00%936K
-Long term capital lease obligation	-43.09%412K	-38.07%493K	-34.03%572K	-30.66%649K	-30.66%649K	--724K	658.10%796K	333.50%867K	225.00%936K	225.00%936K
Derivative product liabilities	--8.76M	--9.12M	--11.04M	----	----	----	----	----	----	----
Other non current liabilities	20.83%49.19M	22.69%46.73M	22.82%44.39M	24.99%42.47M	24.99%42.47M	27.48%40.71M	--38.09M	--36.14M	--33.98M	--33.98M
Total non current liabilities	40.84%58.36M	44.91%56.35M	51.31%56M	23.50%43.12M	23.50%43.12M	29.74%41.43M	36,932.38%38.88M	18,405.50%37.01M	12,022.57%34.91M	12,022.57%34.91M
Total liabilities	35.29%63.95M	40.90%62.22M	47.52%61.95M	22.69%49.93M	22.69%49.93M	27.28%47.27M	703.16%44.16M	864.07%42M	725.81%40.7M	725.81%40.7M
Shareholders'equity
Share capital	20.97%75K	19.35%74K	21.31%74K	3.28%63K	3.28%63K	3.33%62K	3.33%62K	1.67%61K	1.67%61K	1.67%61K
-common stock	20.97%75K	19.35%74K	21.31%74K	3.28%63K	3.28%63K	3.33%62K	3.33%62K	1.67%61K	1.67%61K	1.67%61K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-10.09%-347.97M	-10.90%-340.28M	-11.75%-332.69M	-11.26%-320.92M	-11.26%-320.92M	-13.39%-316.09M	-13.24%-306.82M	-13.14%-297.72M	-12.90%-288.44M	-12.90%-288.44M
Paid-in capital	3.27%313.1M	3.36%311.92M	3.48%310.8M	1.99%304.95M	1.99%304.95M	1.99%303.18M	1.91%301.79M	1.89%300.36M	1.90%298.98M	1.90%298.98M
Gains losses not affecting retained earnings	--5K	---1K	----	----	----	----	----	----	----	----
Total stockholders'equity	-170.75%-34.79M	-468.77%-28.29M	-907.78%-21.81M	-250.01%-15.91M	-250.01%-15.91M	-169.28%-12.85M	-119.70%-4.97M	-91.48%2.7M	-72.07%10.61M	-72.07%10.61M
Total equity	-170.75%-34.79M	-468.77%-28.29M	-907.78%-21.81M	-250.01%-15.91M	-250.01%-15.91M	-169.28%-12.85M	-119.70%-4.97M	-91.48%2.7M	-72.07%10.61M	-72.07%10.61M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data